Li Xiyuan, Wang Xiaomeng, Wang Liangshan, Li Chenglong, Hao Xing, Du Zhongtao, Xie Haixiu, Yang Feng, Wang Hong, Hou Xiaotong
Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China.
Department of Intensive Care Unit, Aviation General Hospital of China Medical University, Beijing, 100012, People's Republic of China.
Infect Drug Resist. 2023 Jun 28;16:4189-4200. doi: 10.2147/IDR.S390599. eCollection 2023.
There was no consensus on the impact of nosocomial infection on In-hospital mortality rate in patients receiving ECMO. This study aimed to investigate the impact of nosocomial infection (NI) on In-hospital mortality rate in adult patients receiving venoarterial extracorporeal membrane oxygenation (VA-ECMO) after cardiac surgery.
This retrospective study included 503 adult patients who underwent VA-ECMO after cardiac surgery. The impact of time-dependent NIs on In-hospital mortality rate within 28 days of ECMO initiation was investigated using a Cox regression model. The cumulative incidence function for death was compared between patients with NIs and those without NIs using a competing risk model.
Within 28 days after ECMO initiation, 206 (41.0%) patients developed NIs, and 220 (43.7%) patients died. The prevalence rates of NIs were 27.8% and 20.3% during and after ECMO therapy, respectively. The incidence rates of NIs during and after ECMO therapy were 49‰ and 25‰, respectively. Time-dependent NI was an independent risk factor for predicting death (hazard ratio = 1.05, 95% confidence interval = 1.00-1.11). The cumulative incidence of death in patients with NI was significantly higher than that in patients without NI at each time point within 28 days of ECMO initiation. (Z = 5.816, P = 0.0159).
NI was a common complication in adult patients who received VA-ECMO after cardiac surgery, and time-dependent NI was an independent risk factor for predicting mortality in these patients. Using a competing risk model, we confirmed that NIs increased the risk of In-hospital mortality rate in these patients.
关于医院感染对接受体外膜肺氧合(ECMO)治疗患者的院内死亡率的影响,目前尚无共识。本研究旨在调查医院感染(NI)对心脏手术后接受静脉-动脉体外膜肺氧合(VA-ECMO)的成年患者院内死亡率的影响。
这项回顾性研究纳入了503例心脏手术后接受VA-ECMO的成年患者。使用Cox回归模型研究时间依赖性医院感染对ECMO启动后28天内院内死亡率的影响。使用竞争风险模型比较有医院感染患者和无医院感染患者的死亡累积发生率函数。
在ECMO启动后28天内,206例(41.0%)患者发生医院感染,220例(43.7%)患者死亡。ECMO治疗期间和治疗后的医院感染患病率分别为27.8%和20.3%。ECMO治疗期间和治疗后的医院感染发病率分别为49‰和25‰。时间依赖性医院感染是预测死亡的独立危险因素(风险比=1.05,95%置信区间=1.00-1.11)。在ECMO启动后28天内的每个时间点,有医院感染患者的死亡累积发生率显著高于无医院感染患者(Z=5.816,P=0.0159)。
医院感染是心脏手术后接受VA-ECMO的成年患者的常见并发症,时间依赖性医院感染是这些患者死亡率的独立危险因素。使用竞争风险模型,我们证实医院感染增加了这些患者的院内死亡风险。